Citadel Advisors’s EQONEX LIMITED Ordinary Shares EQOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-94,340
Closed -$38K 15944
2022
Q3
$38K Buy
94,340
+52,334
+125% +$34.4K ﹤0.01% 11790
2022
Q2
$35K Buy
+42,006
New +$56K ﹤0.01% 12151
2022
Q1
Sell
-44,815
Closed -$85.1K 15091
2021
Q4
$84K Sell
44,815
-4,327
-9% -$16.7K ﹤0.01% 12901
2021
Q3
$159K Buy
49,142
+30,294
+161% +$154K ﹤0.01% 12305
2021
Q2
$123K Sell
18,848
-8,981
-32% -$62.4K ﹤0.01% 12725
2021
Q1
$305K Buy
+27,829
New +$421K ﹤0.01% 10823

Other funds holding EQOS

Citadel Advisors's EQOS Position: Q4 2022 in Review

Citadel Advisors sold out of EQONEX LIMITED Ordinary Shares (EQOS) in Q4 2022, closing a stake of 94,340 shares — an estimated $38K sold.

Citadel Advisors first reported a position in EQOS in Q1 2021 and held it in 6 quarters. The position peaked at $305K in Q1 2021. 1 fund tracked by Wall St. Rank holds EQOS as of Q4 2022.

  • Citadel Advisors reported no remaining EQONEX LIMITED Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 94,340 EQONEX LIMITED Ordinary Shares shares in Q4 2022, an estimated $38K.
  • Citadel Advisors first reported a position in EQONEX LIMITED Ordinary Shares in Q1 2021 and held it in 6 quarters.
  • Citadel Advisors's EQONEX LIMITED Ordinary Shares position peaked at $305K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held EQONEX LIMITED Ordinary Shares as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.